Table of Contents
Journal of Cancer Research
Volume 2014, Article ID 249354, 9 pages
http://dx.doi.org/10.1155/2014/249354
Research Article

BAY 61-3606, CDKi, and Sodium Butyrate Treatments Modulate p53 Protein Level and Its Site-Specific Phosphorylation in Human Vestibular Schwannomas In Vitro

1Department of Human Genetics, NIMHANS, 2900 Hosur Road, Bangalore 560029, India
2Department of Studies in Sericulture/Life Sciences, Jnana Bharathi Campus, Bangalore University, Bangalore 560056, India
3Department of Biotechnology, Bharathiar University, Coimbatore 641046, India
4Department of Neuro Surgery, NIMHANS, Bangalore 560029, India

Received 18 August 2014; Revised 24 September 2014; Accepted 7 October 2014; Published 20 October 2014

Academic Editor: Wenrui Duan

Copyright © 2014 Rohan Mitra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Rohan Mitra, Rohini Keshava, Mathivanan Jothi, Vikas Vazhayil, Indira Devi Bhagavatula, and Rajalakshmi Gope, “BAY 61-3606, CDKi, and Sodium Butyrate Treatments Modulate p53 Protein Level and Its Site-Specific Phosphorylation in Human Vestibular Schwannomas In Vitro,” Journal of Cancer Research, vol. 2014, Article ID 249354, 9 pages, 2014. https://doi.org/10.1155/2014/249354.